期刊文献+

胃癌组织中Survivin和DcR3基因的表达及临床意义 被引量:4

Expression and clinical significance of Survivin and DcR3 mRNA in gastric carcinoma tissue
下载PDF
导出
摘要 目的探讨胃癌组织中Survivin和DcR3基因的表达及其与临床病理特征的关系。方法采用逆转录多聚酶链式反应(RT-PCR)检测50例胃癌组织及其对应的50例正常胃黏膜中Survivin、DcR3 mRNA的表达情况。结果胃癌中Survivin、DcR3 mRNA的阳性表达率均明显高于正常胃黏膜组织(均P<0.01),二者的表达水平在胃癌中呈正相关(P<0.01);Survivin、DcR3 mRNA的表达水平均与胃癌的组织分化程度、淋巴转移、TNM分期有关(均P<0.05)。结论联合检测Survivin和DcR3有助于判断胃癌预后,可能是临床评价胃癌恶性程度的重要指标。 Objective To investigate the expressions of Survivin, DcR3 mRNA in gastric carcinoma and its relationship with clinical and pathological characteristics. Methods The expressions of Survivin, DeR3 mRNA in 50 specimens of gastric carcinoma and its corre-sponding 50 specimens of normal gastric mueosa were examined by reverse transeription-polymerase chain reaction(RT-PCR). Results The positive rates of Survivin, DcR3 mRNA in gastric carcinoma were all significantly higher than those of the normal gastric mucosa. There were significant differences ( all P 〈 0. 01 ), and the expressions of them had positive correlation in gastric carcinoma( P 〈 0.01 ). The expressions of Survivin, DcR3 mRNA were all well associated with histological differentiation, lymph node metastasis and TNM stage ( all P 〈 0.05 ). Conclusions Combined detection of Survivin and DcR3 may help determine the prognosis of gastric cancer, and may be the important index for the degree of malignancy of gastric cancer in clinical evaluation.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2013年第17期4126-4128,共3页 Chinese Journal of Gerontology
基金 辽宁省教育厅2009年度高等学校科研项目计划(No.2009A474)
关键词 胃癌 SURVIVIN基因 DcR3基因 RT-PCR Gastric cancer Survivin gene DcR3 gene RT-PCR
  • 相关文献

参考文献13

  • 1Ambrosini G,Adida C,Ahieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma[ J]. Nat Med, 1997 ;3 (8) :917-21. 被引量:1
  • 2Tamm I, Wang Y, Sausville E, et al. lAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas( CD95 ), Bax, caspases, and antican dmgs[J]. Cancer Res,1998;58(23) :5315-20. 被引量:1
  • 3Sun C, Nettesheim D, Liu Z, et al. Solution structure of human surviving and its binding interface with Smac/Diablo[ J]. Biochemistry,2005;44 (1):11-7. 被引量:1
  • 4Vischioni B, van der Valk P, Span SW,et al. Nuclear localization of sur- vivin is a positive prognostic factor for survival in advanced non-small cell lung cancer[ J]. Ann Onco1,2004 ; 15 ( 11 ) : 1645. 被引量:1
  • 5Lee GH, Joo YE, Kob YS, et aL Expression of survivin in gastric cancer- and its relationship with tumor angiogenesis[ J]. Eur J Gastroenterol Hep- ato1,2006 ; 18 (9) :957-63. 被引量:1
  • 6叶新青,覃思繁,陈发龙.生存素和磷酸酶基因在胃癌中的表达[J].中国基层医药,2010,17(12):1587-1589. 被引量:7
  • 7Pitti RM, Marsters SA, Lawrence DA, et al. Genomic amplification of a de-cay receptor for ligand in lung and colon cancer[ J]. Nature, 1998 ;396 (6712) :699-703. 被引量:1
  • 8Colucci S, Brunetti G, Mori G, et al. Soluble decoy receptor 3 modulates the sm'vival and formation of osteoclasts from multiple myeloma bone dis- ease patients [J]. Leukemia,2009 ;23 ( 11 ) :2139-4-6. 被引量:1
  • 9Yu KY, Kwon B, Ni J,et al. A newly indentified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis [J]. J Biol Chem,1999;274(20) :13733-6. 被引量:1
  • 10Bai C,Connolly B, Metzker ML,et al. Over expression of M68/DcR3 in human gastro intestinal tract tumors independent of gene amplification and its location in a four gene cluster [ J]. Proc Natl Acad Sei USA, 2000 ;97 ( 3 ) : 1230-5. 被引量:1

二级参考文献39

  • 1吕洋,赵坡.胃癌病理学与分子生物学研究进展[J].中华肿瘤防治杂志,2006,13(14). 被引量:13
  • 2Yu K Y, Kwon B, Ni J, et al. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT mediated apoptosis [J]. J Biol Chem, 1999,274 (20): 13733-13736. 被引量:1
  • 3Wu Y Y, Chang Y C, Hsu T L, et al. Sensitization of cells to TRAIL induced apoptosis by decoy receptor 3[J]. J Biol Chem, 2004,279(42) :44211-44218. 被引量:1
  • 4Timmer T, de Vries E G, de Jong S. Fas receptor mediated apoptosis, a clinical application?[J]. J Pathol,2002,196(2):125- 134. 被引量:1
  • 5Pitti R M,Marsters S A,Law rence D A,et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer [J]. Nature, 1998,396(6712) :699-703. 被引量:1
  • 6Bai C, Connolly B,Metzker M L,et al. Overexpression of M68/ DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four gene cluster[J]. Proc Natl Acad Sci U S A, 2000,97(3):1230-1235. 被引量:1
  • 7Otsuki T, Tomokuni A, Sakaguchi H, et al. Over-expression ol the decoy receptor 3(DcR3)gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients[J]. Clin Exp Immunol,2000,119(2) :323-327. 被引量:1
  • 8Wu Y, Han B, Sheng H, et al. Clinical significance of detecting elevated serum DeR3/TR6/M68 in malignant tumor patients[J]. Int J Cancer,2003,105(5) :724-732. 被引量:1
  • 9Tsuji S,Hosotani R,Yoneharx S,et al.Endogenous decoy receptor 3 blacks the growth inhibition signals mediated by Fas ligxnd in human pancreatic adenocxrcinomx[J].Int J Cancer,2003,106(1):17-25. 被引量:1
  • 10LiJ,Yen C,Lian D,et al.PTEN,a putative protein tyrosine phosphatase gene mutated in human brain,breast,and prostate cancer[J].Science,1997,275:1943-1947. 被引量:1

共引文献14

同被引文献29

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部